Webinar by Mikala Egeblad
Cold Spring Harbor Laboratory, Long Island, New York, USA
Mikala obtained degrees in Medicine (B.S., 1993). Human Biology (M.Sc., 1996), and in Cancer Biology (Ph.D., 2000) from the University of Copenhagen, Denmark. She did her dissertation research under the mentorship of Dr. Marja Jäättelä at The Danish Cancer Society. Her postdoctoral training was performed in the laboratory of Dr. Zena Werb at University of California, San Francisco. There, she began developing intravital spinning disk confocal microscopy to understand how the microenvironment influences tumor progression, focusing on innate immune cell responses and protease-mediated extracellular matrix remodeling. She came to Cold Spring Harbor Laboratory in 2009 and established a research group that studies how the tumor microenvironment contributes to therapy resistance and metastasis, primarily focusing on the role of inflammatory cells, including macrophages and neutrophils. Most recently, her lab has been studying the role of neutrophils in COVID-19. She received the Department of Defense Breast Cancer Research Program Era of Hope Scholar Award in 2014 and the Pershing Square Sohn Prize for Young Investigators in Cancer Research in 2017. In 2019, she became chairperson-elect for the American Association for Cancer Research working group on the Tumor Microenvironment.